PATENT CLAIM ANALYSIS

Application Number: 16053164
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["424", "400000"]

Abstract:
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.

Claim (Index 16):
The formulation of  claim 1 , wherein the amount of the preservative is about 0.5 to about 1.2 mg/ml.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15483691', '15805934', '14934752', '15268095', '15081603']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7597372057351017
- 35 USC 102 Novelty (BERT): 0.5717223088069865
- Combined Prediction Score: 0.7409357160422902
- Mean Citation Score: 428.83963000000006
- Max Citation Score: 449.8894
- Similarity Product: 389.5656582123876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test